Medical Excellence Capital

Medical Excellence Capital helps early-stage life science companies advance their therapies and technologies with a focused investment partner. It combines a proprietary network of over 1,100 physician scientists with a team of seasoned venture investors and operators. The fund supports seed, Series A and Series B opportunities in gene therapy, cell therapy, synthetic biology, regenerative medicine, and AI/ML in drug discovery, as a life sciences venture fund. By deploying precision capital and hands-on support, MEC aims to close early-stage gaps and scale deep science ventures.